How much funding has PostEra raised?

PostEra has raised $24.0M in total funding, most recently a Series A round.

Where is PostEra headquartered?

PostEra is headquartered in Boston, Massachusetts, United States.

What industry is PostEra in?

PostEra operates in Drug Discovery, Healthcare, Artificial Intelligence.

PostEra

Q: Who are PostEra's investors?

PostEra's investors include Breyer Capital, I2BF Global Ventures, Lifeforce Capital.

Medicinal Chemistry powered by Machine Learning

Boston, United States · Founded 2019 · $24.0M raised

Drug Discovery

Healthcare

Artificial Intelligence

YC W20

Headquarters: Boston, Massachusetts
Employees: 11–50
Founded: 2019
Website: postera.ai

Total Funding: $24.0M
Last Round: $24.0M Series AJan 2022
Rounds: 1

About

PostEra is building a modern 21st century biopharma. We're using our advances in machine learning to accelerate Medicinal Chemistry and bring more cures to patients. PostEra advances small molecule programs through partnerships with biopharma while also advancing its own internal pipeline. We've raised $26M from top investors and closed $1Bn in AI partnerships, signing multi-year agreements with Amgen, Pfizer and the NIH. PostEra also launched and led the world's largest open-science drug discovery effort; COVID Moonshot.

Summary

PostEra is a Drug Discovery company based in Boston, United States, founded in 2019. It has raised $24.0M in total across 1 round, most recently a $24.0M Series A round in Jan 2022. Investors include Breyer Capital, I2BF Global Ventures and Lifeforce Capital.